SAN DIEGO - Gyre Therapeutics (NASDAQ:GYRE) reported fourth quarter revenue of $27.87 million and provided full year 2025 revenue guidance that fell short of analyst expectations. The commercial-stage ...

"2025 is shaping up to be a pivotal year for Gyre across both our commercial-stage and clinical-stage portfolios. We plan to expand and enhance our commercial product offerings through the additions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This photo shows image of Tamayama Digital Tech Co. pavilion slated to be shown at 2025 World Exposition in Osaka. (Photo courtesy of Tamayama Digital Tech Co.)(Kyodo) TOKYO (Kyodo) -- Japan has ...

For that reason, Miyakawa labeled the Jays as "never trustworthy." Louisville, meanwhile, was faring much better — under 0.4 and over 0.6, respectively. To Creighton's credit, it has improved on ...

We use imaginary lines to help locate where a place is in the world. the Arctic Circle (the North Pole) the Antarctic Circle (the South Pole) the Tropic of Cancer the Tropic of Capricorn and the ...

After hours: March 18 at 7:47:54 PM EDT ...

About five years ago, when another vintage Gallet chronograph watch landed in my collection, I told my wife what I had been daydreaming of for quite a while: “I will buy the Gallet brand someday!” ...

We read every piece of feedback, and take your input very seriously.